FNY Investment Advisers »

Vyne Therapeutics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 25k 0.56

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp (FCRS.U)
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Vyne Therapeutics

None
Frigate Ventures
Nantahala Capital Management
Baker Bros. Advisors
Acadian Asset Management
KVP Capital Advisors
Vanguard Group
Ikarian Capital
ADAR1 Capital Management
Geode Capital Management
Two Sigma Investments
Susquehanna International
Rangeley Capital
Boothbay Fund Management
XTX Topco

View all funds holding Vyne Therapeutics